National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 6) (PB 63 of 2017) (Cth)

PB 63 of 2017

National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 6)

National Health Act 1953

I, PENNY SHAKESPEARE, First Assistant Secretary, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under section 85B of the National Health Act 1953.

Dated 28 August 2017

PENNY SHAKESPEARE

First Assistant Secretary

Technology Assessment and Access Division

Department of Health

1          Name of Instrument

(1)        This Instrument is the National Health (Price and Special Patient Contribution) Amendment Determination 2017 (No. 6).

(2)        This Instrument may also be cited as PB 63 of 2017.

2          Commencement

This Instrument commences on 1 September 2017.

3          Amendment of the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010)

Schedule 1 amends the National Health (Price and Special Patient Contribution) Determination 2010 (PB 109 of 2010).

Schedule 1     Amendments

[1] Schedule 1, entry for Alendronic acid with colecalciferol and calcium

(a)   omit:

Dronalen Plus
D-Cal 1 3.64 10.61

(b)   omit:

ReddyMax Plus
D-Cal 1 3.64 5.87

[2] Schedule 1, entry for Lamotrigine

omit:

Tablet 5 mg Oral Lamictal 56 5.88 7.48

[3] Schedule 1, entry for Salbutamol in the form Nebuliser solution 5 mg (as sulfate) in 2.5 mL single dose units, 30

omit:

Ventolin Nebules 1 3.92 4.38